Sci Adv:肿瘤微环境响应性金纳米粒子 实现肿瘤放疗增敏

2019-04-21 不详 中国医学科学院

2019年4月17日《Advanced Science》杂志发表了中国医学科学院放射医学研究所刘鉴峰研究员团队题为《Enhanced Radio Sensitization by Gold Nanoparticles with Acid‐Triggered Aggregation in Cancer Radiotherapy》的研究论文,报道了一种可特异性提高肿瘤放疗敏感性的新策略。

2019年4月17日《Advanced Science》杂志发表了中国医学科学院放射医学研究所刘鉴峰研究员团队题为《Enhanced Radio Sensitization by Gold Nanoparticles with Acid‐Triggered Aggregation in Cancer Radiotherapy》的研究论文,报道了一种可特异性提高肿瘤放疗敏感性的新策略。

肿瘤放射治疗(RT)在肿瘤病人临床治疗中占有重要的地位。在肿瘤放射治疗期间,反复低剂量的射线有可能促进肿瘤组织产生耐受性,由此导致RT疗效显着降低。放疗增敏剂可以在提高RT疗效的同时降低对正常组织的损伤,目前临床上常用的这类放疗增敏剂为硝基咪唑类或硝基苯衍生物,该类药物往往具有较大的毒副作用,其临床应用因此受到了限制。

刘鉴峰团队采用具有pH响应性多肽修饰具有放疗增敏效果的金纳米粒子,在肿瘤组织的酸性环境下形成金纳米粒子聚集体。这一策略减少了单独分散的金纳米粒子向肿瘤周边组织发生非特异性扩散和重新回到血液循环的现象,将金纳米粒子的放疗增敏值由1.16增大到1.73,从而有助于实现以较低剂量射线获得良好的放疗效果。在提高肿瘤放疗疗效的同时,由于放疗剂量降低以及正常组织内单分散的小粒径金纳米粒子可以从体内较快地清除,大大降低了射线对正常组织的损伤。该研究首次利用金纳米粒子聚集的策略实现了对肿瘤的放疗增敏,被《Advanced Science》杂志选为封底论文进行报道。

原始出处:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1641241, encodeId=03a816412418b, content=<a href='/topic/show?id=11449621556' target=_blank style='color:#2F92EE;'>#金纳米粒子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96215, encryptionId=11449621556, topicName=金纳米粒子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631622767964, createdName=HinsMax, createdTime=Fri Sep 13 00:37:00 CST 2019, time=2019-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772982, encodeId=c2721e729822b, content=<a href='/topic/show?id=89f3e742947' target=_blank style='color:#2F92EE;'>#纳米粒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77429, encryptionId=89f3e742947, topicName=纳米粒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8ae38449394, createdName=zjubiostat, createdTime=Fri Jun 28 13:37:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2023828, encodeId=fd59202382847, content=<a href='/topic/show?id=cfef5e424f8' target=_blank style='color:#2F92EE;'>#放疗增敏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57424, encryptionId=cfef5e424f8, topicName=放疗增敏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Sun Aug 18 09:37:00 CST 2019, time=2019-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580657, encodeId=e001158065eaa, content=<a href='/topic/show?id=d4c6e7430be' target=_blank style='color:#2F92EE;'>#纳米粒子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77430, encryptionId=d4c6e7430be, topicName=纳米粒子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eedc16636878, createdName=ms920641618706883, createdTime=Tue Apr 23 12:37:00 CST 2019, time=2019-04-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1641241, encodeId=03a816412418b, content=<a href='/topic/show?id=11449621556' target=_blank style='color:#2F92EE;'>#金纳米粒子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96215, encryptionId=11449621556, topicName=金纳米粒子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631622767964, createdName=HinsMax, createdTime=Fri Sep 13 00:37:00 CST 2019, time=2019-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772982, encodeId=c2721e729822b, content=<a href='/topic/show?id=89f3e742947' target=_blank style='color:#2F92EE;'>#纳米粒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77429, encryptionId=89f3e742947, topicName=纳米粒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8ae38449394, createdName=zjubiostat, createdTime=Fri Jun 28 13:37:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2023828, encodeId=fd59202382847, content=<a href='/topic/show?id=cfef5e424f8' target=_blank style='color:#2F92EE;'>#放疗增敏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57424, encryptionId=cfef5e424f8, topicName=放疗增敏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Sun Aug 18 09:37:00 CST 2019, time=2019-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580657, encodeId=e001158065eaa, content=<a href='/topic/show?id=d4c6e7430be' target=_blank style='color:#2F92EE;'>#纳米粒子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77430, encryptionId=d4c6e7430be, topicName=纳米粒子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eedc16636878, createdName=ms920641618706883, createdTime=Tue Apr 23 12:37:00 CST 2019, time=2019-04-23, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1641241, encodeId=03a816412418b, content=<a href='/topic/show?id=11449621556' target=_blank style='color:#2F92EE;'>#金纳米粒子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96215, encryptionId=11449621556, topicName=金纳米粒子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631622767964, createdName=HinsMax, createdTime=Fri Sep 13 00:37:00 CST 2019, time=2019-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772982, encodeId=c2721e729822b, content=<a href='/topic/show?id=89f3e742947' target=_blank style='color:#2F92EE;'>#纳米粒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77429, encryptionId=89f3e742947, topicName=纳米粒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8ae38449394, createdName=zjubiostat, createdTime=Fri Jun 28 13:37:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2023828, encodeId=fd59202382847, content=<a href='/topic/show?id=cfef5e424f8' target=_blank style='color:#2F92EE;'>#放疗增敏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57424, encryptionId=cfef5e424f8, topicName=放疗增敏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Sun Aug 18 09:37:00 CST 2019, time=2019-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580657, encodeId=e001158065eaa, content=<a href='/topic/show?id=d4c6e7430be' target=_blank style='color:#2F92EE;'>#纳米粒子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77430, encryptionId=d4c6e7430be, topicName=纳米粒子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eedc16636878, createdName=ms920641618706883, createdTime=Tue Apr 23 12:37:00 CST 2019, time=2019-04-23, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1641241, encodeId=03a816412418b, content=<a href='/topic/show?id=11449621556' target=_blank style='color:#2F92EE;'>#金纳米粒子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96215, encryptionId=11449621556, topicName=金纳米粒子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631622767964, createdName=HinsMax, createdTime=Fri Sep 13 00:37:00 CST 2019, time=2019-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772982, encodeId=c2721e729822b, content=<a href='/topic/show?id=89f3e742947' target=_blank style='color:#2F92EE;'>#纳米粒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77429, encryptionId=89f3e742947, topicName=纳米粒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8ae38449394, createdName=zjubiostat, createdTime=Fri Jun 28 13:37:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2023828, encodeId=fd59202382847, content=<a href='/topic/show?id=cfef5e424f8' target=_blank style='color:#2F92EE;'>#放疗增敏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57424, encryptionId=cfef5e424f8, topicName=放疗增敏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Sun Aug 18 09:37:00 CST 2019, time=2019-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580657, encodeId=e001158065eaa, content=<a href='/topic/show?id=d4c6e7430be' target=_blank style='color:#2F92EE;'>#纳米粒子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77430, encryptionId=d4c6e7430be, topicName=纳米粒子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eedc16636878, createdName=ms920641618706883, createdTime=Tue Apr 23 12:37:00 CST 2019, time=2019-04-23, status=1, ipAttribution=)]

相关资讯

Nano Lett:新的纳米组合物具有良好的抑瘤效果

近期,国际著名学术期刊《纳米通讯》(Nano letters)在线发表了北京大学药学院张强教授研究团队的最新研究成果:“Peptide–Drug Conjugate-Based Nanocombination Actualizes Breast Cancer Treatment by Maytansinoid and Photothermia with the Assistance of Fluo

全国肿瘤防治:胃病不打紧?你敢信吗

我国历来是胃癌高发国家,每年新发病例几乎占到全球新发病例的一半,死亡率更是远远高于日本、韩国。那么胃病会变成胃癌吗,胃癌要怎么预防? 北京大学肿瘤医院院长季加孚说,防治胃癌,千万不能踩6个误区。

高度重视肿瘤相关静脉血栓栓塞的防与治

众所周知,血液肿瘤患者深静脉血栓的发生率大约是正常人的4倍,而化疗或者靶向治疗后的患者深静脉血栓发生率又是肿瘤患者的将近4倍,因此治疗后的患者深静脉血栓的发生率大约比正常人高出16倍 。深静脉血栓是血液肿瘤患者中最常见的疾病,20年前,我国并没有深静脉血栓的防治共识和指南,直至15年前中国第一版肿瘤深静脉血栓专家共识的出现。当时共识由我和秦叔逵教授执笔,因出版较早,共识主要包括教育、原理和一些简单

性别差异在肿瘤中的全面分析

性别是影响个体营养能量代谢和癌症发生发展的关键因素。不仅是在某些性别特异性癌症(如女性卵巢癌和男性的前列腺癌),而且在其他多种癌症上,男性和女性在发病率、侵袭性,预后和治疗反应上均存在显着的差异。现代肿瘤医学提出了精准医疗(precision medicine),更加要求我们能够不断的区分不同人群的不同肿瘤,不能仅仅停留在组织器官(如胃癌、肠癌等)这样简单的分类上。

肿瘤患者简明膳食自评工具的发明与研究

欧洲和北美的研究均证实,40%~60%的肿瘤患者存在程度不等的体重下降,其中,营养不良发生率30.9%。我国肿瘤营养不良流行病学调查研究显示超过50%的肿瘤患者存在营养不良。肿瘤患者食欲差、饮食量降低,并常伴有慢性炎症反应及代谢损伤,导致营养不良发生率明显高于其他慢性病。肿瘤患者出现体重下降或营养不良导致了较差的临床结局,包括治疗顺应性降低,副反应增加,生活质量下降,生存期缩短。因此肿瘤患者的营养

Genet Med:构建数学模型,评估全基因测序的疾病防治效果和成本效果

近些年来基因组测序技术得到快速发展,很多致病风险基因被陆续发现,针对全民进行基因组普查是否能够实现早期预防、早诊早治并具有较高的经济效益是亟待解决的热点问题。基于此,西安交大公共卫生学院张磊教授构建了数学模型,评估了针对澳大利亚18-25岁人群7种疾病进行全基因测序的疾病防治效果和成本效果。近日,该研究成果“Population genomic screening of all young adu